FDA Guidance

Official FDA guidance documents for medical devices and radiation-emitting products

106 resources
Home / Resources / FDA Guidance
106 resources

FDA and Industry Actions on 510(k) Submissions: Effect on FDA Review Clock and Goals

FDA Guidance 2017-10-01 FDA Guidance

Final FDA guidance on 510(k). Published 2017 by CDRH/CBER.

View Document

User Fees for 513(g) Requests for Information

FDA Guidance 2017-10-01 FDA Guidance

Final FDA guidance on user fees. Published 2017 by CDRH/CBER.

View Document

Deciding When to Submit a 510(k) for a Software Change to an Existing Device

FDA Guidance 2017-10-01 FDA Guidance

Final FDA guidance on software & digital health. Published 2017 by CDRH/CBER.

View Document

Technical Considerations for Additive Manufactured Medical Devices

FDA Guidance 2017-12-01 FDA Guidance

Final FDA guidance on manufacturing. Published 2017 by CDRH/CBER.

View Document

Unique Device Identification: Direct Marking of Devices

FDA Guidance 2017-11-01 FDA Guidance

Final FDA guidance on udi. Published 2017 by CDRH/CBER.

View Document

Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based IVDs

FDA Guidance 2018-04-01 FDA Guidance

Final FDA guidance on ivd & diagnostics. Published 2018 by CDRH/CBER.

View Document

Acceptance of Clinical Data to Support Medical Device Applications and Submissions: FAQ

FDA Guidance 2018-02-01 FDA Guidance

Final FDA guidance on clinical evidence. Published 2018 by CDRH/CBER.

View Document

FDA Categorization of IDE Devices to Assist CMS with Coverage Decisions

FDA Guidance 2017-12-01 FDA Guidance

Final FDA guidance on ide. Published 2017 by CDRH/CBER.

View Document

Medical Device Accessories — Describing Accessories and Classification Pathways

FDA Guidance 2017-12-01 FDA Guidance

Final FDA guidance on classification. Published 2017 by CDRH/CBER.

View Document

Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices

FDA Guidance 2018-09-01 FDA Guidance

Final FDA guidance on standards & conformity. Published 2018 by CDRH/CBER.

View Document

Use of Electronic Health Record Data in Clinical Investigations

FDA Guidance 2018-07-01 FDA Guidance

Final FDA guidance on clinical evidence. Published 2018 by CDRH/CBER.

View Document

Logical Observation Identifiers Names and Codes for In Vitro Diagnostic Tests

FDA Guidance 2018-06-01 FDA Guidance

Final FDA guidance on ivd & diagnostics. Published 2018 by CDRH/CBER.

View Document

User Fees and Refunds for Premarket Approval Applications and Device BLAs

FDA Guidance 2018-12-01 FDA Guidance

Final FDA guidance on user fees. Published 2018 by CDRH/CBER.

View Document

Manufacturing Site Change Supplements: Content and Submission

FDA Guidance 2018-12-01 FDA Guidance

Final FDA guidance on manufacturing. Published 2018 by CDRH/CBER.

View Document

Benefit-Risk Factors to Consider When Determining Substantial Equivalence in 510(k) Submissions

FDA Guidance 2018-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2018 by CDRH/CBER.

View Document

Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo

FDA Guidance 2019-08-01 FDA Guidance

Final FDA guidance on benefit-risk. Published 2019 by CDRH/CBER.

View Document

Unique Device Identification: Convenience Kits

FDA Guidance 2019-04-01 FDA Guidance

Final FDA guidance on udi. Published 2019 by CDRH/CBER.

View Document

The Least Burdensome Provisions: Concept and Principles

FDA Guidance 2019-02-01 FDA Guidance

Final FDA guidance on submission process. Published 2019 by CDRH/CBER.

View Document

Humanitarian Device Exemption (HDE) Program

FDA Guidance 2019-09-01 FDA Guidance

Final FDA guidance on hde. Published 2019 by CDRH/CBER.

View Document

Refuse to Accept Policy for 510(k)s

FDA Guidance 2019-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.

View Document

The Abbreviated 510(k) Program

FDA Guidance 2019-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.

View Document

The Special 510(k) Program

FDA Guidance 2019-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.

View Document

Annual Reports for Approved Premarket Approval Applications (PMA)

FDA Guidance 2019-12-01 FDA Guidance

Final FDA guidance on pma. Published 2019 by CDRH/CBER.

View Document

Safety and Performance Based Pathway

FDA Guidance 2019-09-01 FDA Guidance

Final FDA guidance on 510(k). Published 2019 by CDRH/CBER.

View Document
Loading more resources…
Scroll to Top